Case Study: Solving API Challenges Through Integrated Route & Solid-State Strategy
23 July 2026
Overview
A US biotech developing combined small molecule and biologic immunotherapies partnered with us for our API development expertise.
This study highlights our rapid development of a scalable synthesis route for a new drug substance analogue and determination of the most suitable salt form for formulation.
Download a copy of our case study today and contact our experts to find out even more.